As a result, FDA has not approved Sun Pharma's Imatinib Mesylate Tablet products for this indication. For safety information please refer to U.S. Full Prescribing Information at www.imatinibrx.com ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced the launch of Imatinib Mesylate Tablets, USP, a therapeutic equivalent generic version of Gleevec Tablets in the U.S. market approved by ...

The Food and Drug Administration has cleared Zydus Cadila’s imatinib mesylate tablets, in dosage strengths of 100 mg and 400 mg. The product is the generic of Novartis’ Gleevec tablets.

Background and Objective: Imatinib mesylate is the first effective therapy for advanced unresectable gastrointestinal stromal tumours (GIST). Adoption of this therapy in clinical practice is ...

3. Imatinib Mesylate tablets, known by the brand name Stason, is a generic form of Novartis’ Gleevec tablets. The chemotherapy drug slows the growth of cancer cells. 4. Glenmark Pharmaceuticals ...

Shares of Shilpa Medicare rose 3.8 percent intraday Friday after company received US Food and Drug Administration (USFDA) approval for its ANDA, Imatinib Mesylate Tablets, 100 mg and 400 mg.

The recall involves various medications, such as Imatinib Mesylate Tablets 100 mg and 400 mg; Pregabalin Capsules 50 mg, 75 mg, 100 mg, and 150 mg; Sevelamer Carbonate Tablets 800 mg; as well as ...

MUMBAI, India & CRANBURY, N.J.--(BUSINESS WIRE)--As part of the company’s philosophy of putting patients' interests first, Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

positive unrespectable and/or metastatic malignant gastrointestinal stromal tumors (GIST)." FDA has not approved Sun Pharma's Imatinib Mesylate Tablet products for this indication.